Features Screener Stocks Charts
Sign In Sign Up

Granules India Limited Income Statement

NSE:GRANULES | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year GRANULES income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 45.11B 44.95B
Cost of Revenue -20.21B -17.26B
Gross Profit 24.90B 27.69B
Sales, General & Admin -16.29B -18.11B
Operating Income 6.53B 7.33B
Profit Before Tax 5.47B 6.60B
Net Income 4.05B 5.02B
Diluted Shares 242.35M 242.50M
Diluted EPS 16.72 20.68

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025